UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lipid peroxidation generates biologically active phospholipids including oxidatively N-modified phospholipids

Chemistry and physics of lipids, 2014-07, Vol.181, p.1-33

2014

Volltextzugriff (PDF)

Osteonecrosis in Gaucher disease in the era of multiple therapies: Biomarker set for risk stratification from a tertiary referral center

eLife, 2023-05, Vol.12

2023

Volltextzugriff (PDF)

Leptogenic effects of NAPE require activity of NAPE-hydrolyzing phospholipase D

Journal of lipid research, 2017-08, Vol.58 (8), p.1624-1635

2017

Volltextzugriff (PDF)

Neuroinflammation in neuronopathic Gaucher disease: Role of microglia and NK cells, biomarkers, and response to substrate reduction therapy

eLife, 2022-08, Vol.11

2022

Volltextzugriff (PDF)

Incremental biomarker and clinical outcomes after switch from enzyme therapy to eliglustat substrate reduction therapy in Gaucher disease

Molecular genetics and metabolism reports, 2021-12, Vol.29, p.100798-100798, Article 100798

2021

Volltextzugriff (PDF)

Analysis of Single-Cell RNA-seq Data by Clustering Approaches

Current bioinformatics, 2019-01, Vol.14 (4), p.314-322

2019

Volltextzugriff (PDF)

An efficient Burrows–Wheeler transform-based aligner for short read mapping

Computational biology and chemistry, 2024-06, Vol.110, p.108050-108050, Article 108050

2024

Volltextzugriff (PDF)

A liquid chromatography–tandem mass spectrometry method for measurement of N-modified phosphatidylethanolamines

Analytical biochemistry, 2010, Vol.405 (2), p.236-245

2010

Volltextzugriff (PDF)

Isolevuglandin-modified phosphatidylethanolamine is metabolized by NAPE-hydrolyzing phospholipase D

Journal of lipid research, 2013-11, Vol.54 (11), p.3151-3157

2013

Volltextzugriff (PDF)

Glucosylceramide synthase modulation ameliorates murine renal pathologies and promotes macrophage effector function in vitro

Communications biology, 2024-08, Vol.7 (1), p.932-15, Article 932

2024

Volltextzugriff (PDF)

Dietary Fatty Acids Control the Species of N‑Acyl-Phosphatidylethanolamines Synthesized by Therapeutically Modified Bacteria in the Intestinal Tract

ACS infectious diseases, 2018-01, Vol.4 (1), p.3-13

2018

Volltextzugriff (PDF)

Bisquaternary pyridinium oximes: Comparison of in vitro reactivation potency of compounds bearing aliphatic linkers and heteroaromatic linkers for paraoxon-inhibited electric eel and recombinant human acetylcholinesterase

Bioorganic & medicinal chemistry, 2010-01, Vol.18 (2), p.787-794

2010

Volltextzugriff (PDF)

New series of monoquaternary pyridinium oximes: Synthesis and reactivation potency for paraoxon-inhibited electric eel and recombinant human acetylcholinesterase

Bioorganic & medicinal chemistry letters, 2009-09, Vol.19 (17), p.5101-5104

2009

Volltextzugriff (PDF)

CD63 as the potential universal biomarker for lysosomal diseases

Molecular genetics and metabolism, 2023-02, Vol.138 (2), p.107365, Article 107365

2023

Volltextzugriff (PDF)

Microglia ferroptosis is regulated by SEC24B and contributes to neurodegeneration

Nature neuroscience, 2023-01, Vol.26 (1), p.12-26

2023

Volltextzugriff (PDF)

Inhibition of acetylcholinesterase by chromophore-linked fluorophosphonates

Bioorganic & medicinal chemistry letters, 2010-02, Vol.20 (3), p.1194-1197

2010

Volltextzugriff (PDF)

RIPK1 activation mediates neuroinflammation and disease progression in multiple sclerosis

Cell reports (Cambridge), 2021-05, Vol.35 (6), p.109112-109112, Article 109112

2021

Volltextzugriff (PDF)

MALAT1 accelerates proliferation and inflammation and suppresses apoptosis of endometrial stromal cells via the microRNA-142-3p/CXCR7 axis

Reproductive biology, 2022-09, Vol.22 (3), p.100675, Article 100675

2022

Volltextzugriff (PDF)

Severe pulmonary arterial hypertension in Gaucher disease type 1

Molecular genetics and metabolism, 2023-02, Vol.138 (2), p.107021, Article 107021

2023

Volltextzugriff (PDF)

Osteonecrosis in the era of Gaucher disease therapies

Molecular genetics and metabolism, 2023-02, Vol.138 (2), p.107020, Article 107020

2023

Volltextzugriff (PDF)

Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity

The Journal of clinical investigation, 2014-08, Vol.124 (8), p.3391-3406

2014

Volltextzugriff (PDF)

Biomarkers profiling in patients with mucopolysaccharidosis and correlation with other primary biomarkers

Molecular genetics and metabolism, 2023-02, Vol.138 (2), p.107000, Article 107000

2023

Volltextzugriff (PDF)

AAV-ARSA mediated gene replacement for the treatment of metachromatic leukodystrophy

Molecular genetics and metabolism, 2024-02, Vol.141 (2), p.108012, Article 108012

2024

Volltextzugriff (PDF)

Anti-human-TfR-GAA efficiently clears CNS and muscle glycogen in a translatable hTfR-KI/Pompe disease mouse model

Molecular genetics and metabolism, 2024-02, Vol.141 (2), p.108062, Article 108062

2024

Volltextzugriff (PDF)

Identification of novel bioactive aldehyde-modified phosphatidylethanolamines formed by lipid peroxidation

Free radical biology & medicine, 2012-09, Vol.53 (6), p.1226-1238

2012

Volltextzugriff (PDF)

1 – 25 von 91

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(84)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Life Sciences & Biomedicine
(33)
Animals
(20)
Humans
(14)
Biochemistry & Molecular Biology
(12)
Mice
(11)
Inflammation
(8)
Phosphatidylethanolamines - Metabolism
(7)
Physical Sciences
(7)
Cell Biology
(6)
Chemistry
(6)
Chemistry, Medicinal
(6)
Lipid Peroxidation
(6)
Male
(6)
Mice, Inbred C57bl
(6)
Oxidative Stress
(6)
Pharmacology & Pharmacy
(6)
Apoptosis
(5)
Acetylcholinesterase
(4)
Biology
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Lipid peroxidation generates biologically active phospholipids including oxidatively N-modified phospholipids

Osteonecrosis in Gaucher disease in the era of multiple therapies: Biomarker set for risk stratification from a tertiary referral center

Leptogenic effects of NAPE require activity of NAPE-hydrolyzing phospholipase D

Neuroinflammation in neuronopathic Gaucher disease: Role of microglia and NK cells, biomarkers, and response to substrate reduction therapy

Incremental biomarker and clinical outcomes after switch from enzyme therapy to eliglustat substrate reduction therapy in Gaucher disease

Analysis of Single-Cell RNA-seq Data by Clustering Approaches

An efficient Burrows–Wheeler transform-based aligner for short read mapping

A liquid chromatography–tandem mass spectrometry method for measurement of N-modified phosphatidylethanolamines

Isolevuglandin-modified phosphatidylethanolamine is metabolized by NAPE-hydrolyzing phospholipase D

Glucosylceramide synthase modulation ameliorates murine renal pathologies and promotes macrophage effector function in vitro

Dietary Fatty Acids Control the Species of N‑Acyl-Phosphatidylethanolamines Synthesized by Therapeutically Modified Bacteria in the Intestinal Tract

Bisquaternary pyridinium oximes: Comparison of in vitro reactivation potency of compounds bearing aliphatic linkers and heteroaromatic linkers for paraoxon-inhibited electric eel and recombinant human acetylcholinesterase

New series of monoquaternary pyridinium oximes: Synthesis and reactivation potency for paraoxon-inhibited electric eel and recombinant human acetylcholinesterase

CD63 as the potential universal biomarker for lysosomal diseases

Microglia ferroptosis is regulated by SEC24B and contributes to neurodegeneration

Inhibition of acetylcholinesterase by chromophore-linked fluorophosphonates

RIPK1 activation mediates neuroinflammation and disease progression in multiple sclerosis

MALAT1 accelerates proliferation and inflammation and suppresses apoptosis of endometrial stromal cells via the microRNA-142-3p/CXCR7 axis

Severe pulmonary arterial hypertension in Gaucher disease type 1

Osteonecrosis in the era of Gaucher disease therapies

Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity

Biomarkers profiling in patients with mucopolysaccharidosis and correlation with other primary biomarkers

AAV-ARSA mediated gene replacement for the treatment of metachromatic leukodystrophy

Anti-human-TfR-GAA efficiently clears CNS and muscle glycogen in a translatable hTfR-KI/Pompe disease mouse model

Identification of novel bioactive aldehyde-modified phosphatidylethanolamines formed by lipid peroxidation

Suchergebnisse filtern